We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$174M
AUM Growth
–
Cap. Flow
+$176M
Cap. Flow %
100.96%
Top 10 Hldgs %
24.86%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.91M
2
BMY icon
Bristol-Myers Squibb
BMY
+$4.88M
3
MRK icon
Merck
MRK
+$4.75M
4
VZ icon
Verizon
VZ
+$4.67M
5
T icon
AT&T
T
+$4.31M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Technology 14.15%
3 Industrials 11.26%
4 Energy 10.86%
5 Consumer Staples 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
51
Teva Pharmaceuticals
TEVA
$40.8B
$1.33M 0.76%
+33,952
New +$1.32M
HRB icon
52
H&R Block
HRB
$5.58B
$1.28M 0.73%
+46,078
New +$1.31M
KMB icon
53
Kimberly-Clark
KMB
$36.3B
$1.27M 0.73%
+13,611
New +$1.31M
XOM icon
54
ExxonMobil
XOM
$644B
$1.2M 0.69%
+13,258
New +$1.19M
CVS icon
55
CVS Health
CVS
$133B
$1.12M 0.64%
+19,664
New +$1.14M
TRP icon
56
TC Energy
TRP
$70.2B
$1.04M 0.59%
+24,050
New +$1.13M
BMS
57
DELISTED
Bemis
BMS
$1.03M 0.59%
+26,398
New +$1.05M
CVD
58
DELISTED
COVANCE INC.
CVD
$1M 0.58%
+13,200
New +$987K
UGI icon
59
UGI
UGI
$7.74B
$946K 0.54%
+36,300
New +$956K
FTR
60
DELISTED
Frontier Communications Corp.
FTR
$875K 0.5%
+14,398
New +$891K
PSX icon
61
Phillips 66
PSX
$84.9B
$826K 0.47%
+14,027
New +$881K
HPQ icon
62
HP
HPQ
$24.9B
$821K 0.47%
+72,886
New +$744K
APD icon
63
Air Products & Chemicals
APD
$65.7B
$803K 0.46%
+9,475
New +$796K
TWC
64
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$792K 0.45%
+7,039
New +$681K
MANT
65
DELISTED
Mantech International Corp
MANT
$773K 0.44%
+29,600
New +$786K
EMR icon
66
Emerson Electric
EMR
$83.9B
$747K 0.43%
+13,700
New +$770K
TTE icon
67
TotalEnergies
TTE
$195B
$738K 0.42%
+15,150
New +$748K
GLW icon
68
Corning
GLW
$119B
$724K 0.42%
+50,850
New +$739K
NVS icon
69
Novartis
NVS
$297B
$709K 0.41%
+11,188
New +$728K
SO icon
70
Southern Company
SO
$109B
$686K 0.39%
+15,548
New +$715K
JPM icon
71
JPMorgan Chase
JPM
$935B
$685K 0.39%
+12,975
New +$660K
NWL icon
72
Newell Brands
NWL
$2.38B
$663K 0.38%
+25,250
New +$671K
AVY icon
73
Avery Dennison
AVY
$13B
$659K 0.38%
+15,400
New +$657K
RDS.A
74
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$639K 0.37%
+10,022
New +$663K
PNR icon
75
Pentair
PNR
$10.4B
$606K 0.35%
+15,635
New +$585K
1 2
3
4 5

Similar funds

GCP
Gill Capital Partners Denver, Colorado $348M AUM 14.74% 1-Year Est. Return
AWA
Argos Wealth Advisors Sacramento, California $348M AUM
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return
LAM
LOM Asset Management Hamilton $348M AUM 29.69% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $346M AUM 25.49% 1-Year Est. Return
VW
Vance Wealth Santa Clarita, California $346M AUM 19.74% 1-Year Est. Return
1CP
11 Capital Partners Darien, Connecticut $348M AUM 19.84% 1-Year Est. Return
NC
Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

Argyle Capital Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Argyle Capital Management, which disclosed 108 positions worth $174M. Its ten largest holdings account for 25% of the portfolio.

Its largest position is Pfizer: 177,740 shares worth $4.72M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Industrials.

  • Argyle Capital Management's largest Q2 2013 buy was Pfizer: 177,740 shares worth $4.72M.
  • Argyle Capital Management's ten largest holdings make up 25% of its $174M portfolio in Q2 2013.
  • Argyle Capital Management disclosed 108 positions in Q2 2013, its first 13F filing on record.

Based on Argyle Capital Management's 13F filing for Q2 2013, filed 31 Jul 2013.